RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1

[1]  R. Xavier,et al.  Identification of a Novel Ras-Regulated Proapoptotic Pathway , 2002, Current Biology.

[2]  G. Pfeifer,et al.  Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas , 2001, International journal of cancer.

[3]  A. Adjei,et al.  Blocking oncogenic Ras signaling for cancer therapy. , 2001, Journal of the National Cancer Institute.

[4]  G. Pfeifer,et al.  The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas , 2001, Oncogene.

[5]  A. Protopopov,et al.  The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Minna,et al.  Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. , 2001, Journal of the National Cancer Institute.

[7]  J. Minna,et al.  Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours , 2001, Oncogene.

[8]  D. Bar-Sagi.  A Ras by Any Other Name , 2001, Molecular and Cellular Biology.

[9]  A. Bell,et al.  Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis* , 2000, The Journal of Biological Chemistry.

[10]  D. Bar-Sagi,et al.  Ras and Rho GTPases A Family Reunion , 2000, Cell.

[11]  P. Crespo,et al.  Ras proteins in the control of the cell cycle and cell differentiation , 2000, Cellular and Molecular Life Sciences CMLS.

[12]  Chun Xing Li,et al.  Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 , 2000, Nature Genetics.

[13]  C. Der,et al.  Understanding Ras: 'it ain't over 'til it's over'. , 2000, Trends in cell biology.

[14]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.

[15]  J. Thorner,et al.  Random Mutagenesis and Functional Analysis of the Ran-binding Protein, RanBP1* , 2000, The Journal of Biological Chemistry.

[16]  M. J. van den Bent,et al.  Genetic aberrations in oligodendroglial tumours: an analysis using comparative genomic hybridization (CGH) , 1999, The Journal of pathology.

[17]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[18]  J. Bos.  All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral , 1998, The EMBO journal.

[19]  Channing J Der,et al.  Increasing complexity of Ras signaling , 1998, Oncogene.

[20]  J. Minna,et al.  Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene , 1998, Oncogene.

[21]  S. Hanash,et al.  GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas , 1998, Oncogene.

[22]  J. Avruch,et al.  Identification of Nore1 as a Potential Ras Effector* , 1998, The Journal of Biological Chemistry.

[23]  C. Der,et al.  14-3-3 ζ Negatively Regulates Raf-1 Activity by Interactions with the Raf-1 Cysteine-rich Domain* , 1997, The Journal of Biological Chemistry.

[24]  P. Laird,et al.  COBRA: a sensitive and quantitative DNA methylation assay. , 1997, Nucleic acids research.

[25]  F. McCormick,et al.  Signal transduction from multiple Ras effectors. , 1997, Current opinion in genetics & development.

[26]  A. Wittinghofer,et al.  How Ras-related proteins talk to their effectors. , 1996, Trends in biochemical sciences.

[27]  Chris P. Ponting,et al.  A novel family ofras-binding domains , 1996 .

[28]  A. Zetterberg,et al.  Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. , 1995, Cancer research.

[29]  A. Newton.  Protein Kinase C: Seeing two domains , 1995, Current Biology.

[30]  A. Wittinghofer,et al.  Ras‐effector interactions, the problem of specificity , 1995, FEBS letters.

[31]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[32]  Eugenio Santos,et al.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene , 1982, Nature.

[33]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.